Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach and enhance results.

Sartorius Stedim Biotech SA / Key word (s): Quarter Results/Forecast Sartorius Stedim Biotech publishes unaudited first quarter results for 2025 16-Apr-2025 / 07:00 CET/CEST ...

The Basel Area in Switzerland is home to one of Europe’s brightest biotech ecosystems. Over the years, it has proven to be the favored location for many of the world’s biggest, best, and newest ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

It’s a biotech en­vi­ron­ment with­out many good choic­es. Even be­fore Pres­i­dent Don­ald Trump’s tar­iff an­nounce­ment pushed stock in­dices to­ward a bear mar­ket ...

However, the prospect of future industry-specific tariffs could intensify selling pressure on biotech stocks. Despite the uncertainty, top hedge fund managers have invested millions of dollars in ...

In a scientific breakthrough that could forever change how humans interact with our planet, Colossal Biosciences said it has brought back an extinct animal that last walked the Earth roughly ...

Caitlin O'Kane is a New York City journalist who works on the CBS News social media team as a senior manager of content and production. She writes about a variety of topics and produces "The ...

Sartorius, a German bio-corporation, announced on the 8th that it will invest $550 million (780 billion won) to build facilities and production facilities in Songdo International City, Incheon ...

A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...

Legend Biotech has no tariff exposure and manufactures Carvykti entirely in the U.S. for both U.S. and EU markets. HC Wainwright maintains a $75 target, citing Carvykti’s strong efficacy and ...